Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review Online Course 2025
Mayo Hematology Review 2025 study materials cover benign and malignant hematology, solid tumors and oncology practice updates. This MedicalAmboss listing provides course files, not Mayo Clinic registration, platform access or examination credit.
Information:
Original publisher course opening date: August 28, 2025. Publisher access dates are separate from this store’s file-delivery terms.
COURSE DIRECTORS: Kebede H. Begna, M.D., Tanios S. Bekaii-Saab, M.D., Naseema Gangat, M.B.B.S., Wilson I. Gonsalves, M.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., Sameer A. Parikh, M.B.B.S., and Kathryn J. Ruddy, M.D.
The program combines a hematology oncology board review with clinical practice topics. It is intended for physicians and fellows reviewing blood disorders, cancer assessment and treatment approaches; educational use does not establish clinical competence.
This online course features repurposed content from the in-person Hematology & Medical Oncology Practice Updates and Board Review 2025 event.
Target Audience
This activity is appropriate for physicians and resident fellows.
Learning Objectives
- Recognize evidence-based practices for managing patients with bleeding and/or clotting disorders.
- Identify appropriate molecular tests, such as next-generation sequencing, for cancer diagnosis.
- Recognize how to incorporate the most current cancer treatment options, such as immunotherapy or targeted therapy, into clinical practice.
Listed Program Topics
The retained lecture titles, speakers and durations describe the publisher program. They have not been independently checked against the delivered folder.
| 2025 publisher program — study-file topic inventory | ||
| Duration | Lecture Title | Speaker(s) |
| 0:25:20 | Early Breast Cancer Locoregional Therapy | Tina Hieken, M.D. |
| 0:35:08 | HER2-Positive Breast Cancer | Pooja Advani, M.B.B.S., M.D. |
| 0:34:02 | Systemic Therapy for TNBC: Curative & Palliative | Roberto Leon Ferre, M.D. |
| 0:37:40 | Systemic Therapy for ER+/HER2 Breast Cancer Therapy | Tufia Haddad, M.D. |
| 0:31:21 | Management of Early-Stage Colorectal Cancer | Jeremy Jones, M.D. |
| 0:34:08 | Advanced Colorectal Cancer (CRC) | Tanios Bekaii-Saab, M.D. |
| 0:35:44 | Upper GI Cancer | Bassam Sonbol, M.D. |
| 0:29:30 | Hepatobiliary Cancers | Mitesh Borad, M.D. |
| 0:24:32 | Pancreatic Cancer 2025 | Robert McWilliams, M.D. |
| 0:31:10 | Update on Management of Early Stage NSCLC | Vinicius Ernani, M.D. |
| 0:37:26 | Advanced Stage IV NSCLC | Rami Manochakian, M.D. |
| 0:24:33 | Small Cell Lung Cancer | Kaushal Parikh, M.B.B.S. |
| 0:23:14 | Other Thoracic Malignancies | Konstantinos Leventakos, M.D., Ph.D. |
| 0:33:42 | Head and Neck Cancer | Katharine Price, M.D. |
| 0:21:24 | Neuro-Oncology | Alyx Porter, M.D. |
| 0:24:05 | Sarcoma | Steve Robinson, M.B.B.S. |
| 0:28:42 | Bladder Cancer Update | Parminder Singh, M.D. |
| 0:32:57 | RCC in 2025: What’s New for the Practicing Oncologist? | Yousef Zakharia |
| 0:26:04 | Germ Cell Cancers | Lance Pagliaro, M.D. |
| 0:33:24 | Prostate Cancer Board Review | Dan Childs, M.D. |
| 0:40:18 | Ovarian Cancer | Andrea Wahner Hendrickson, M.D. |
| 0:28:42 | Updates in Endocrine Malignancies | Mabel Ryder, M.D. |
| 0:26:59 | Hereditary Cancer Syndromes | Siddhartha Yadav, M.B.B.S., M.D. |
| 0:28:43 | Transfusion Medicine for Hematologist/Medical Oncologist | Jeffrey Winters, M.D. |
| 0:34:13 | Management of Thrombosis in Cancer | Aneel Ashrani, M.D., M.S. |
| 0:30:05 | Palliative Care and Symptom Management | Jacob Strand, M.D. |
| 0:23:25 | Hodgkin Lymphoma | Stephen Ansell, M.D., Ph.D. |
| 0:32:04 | Aggressive B-Cell Lymphoma | Grzegorz Nowakowski, M.D. |
| 0:24:53 | Chronic Lymphocytic Leukemia | Sameer Parikh, M.B.B.S. |
| 0:29:58 | Follicular and Mantle Cell Lymphoma Update | Thomas Witzig, M.D. |
| 0:25:11 | Other Indolent Non-Hodgkin Lymphomas | Thomas Habermann, M.D. |
| 0:20:55 | T cell lymphoma | Allison Rosenthal, D.O. |
| 0:26:33 | MGUS / Smoldering Myeloma | Angela Dispenzieri, M.D. |
| 0:30:59 | Newly Diagnosed Multiple Myeloma | Vivek Roy, M.D. |
| 0:38:27 | CAR-T in Myeloma | Yi Lin, M.D., Ph.D. |
| 0:25:53 | Waldenström’s Macroglobulinemia and Amyloidosis | Morie Gertz, M.D. |
| 0:34:40 | Myeloproliferative Neoplasms, Mastocytosis, and Eosinophilic Disorders | Ayalew Tefferi, M.D. |
| 0:30:10 | Myelodysplastic Syndromes and Bone Marrow Failure States – 2025 Updates | Mrinal Patnaik, M.B.B.S. |
| 0:19:22 | Chronic Myeloid Leukemia | Kebede Begna, M.D. |
| 0:23:12 | Acute Myeloid Leukemia | Naseema Gangat, M.B.B.S. |
| 0:33:38 | Update in Acute Lymphoblastic Leukemia | Mark Litzow, M.D. |
| 0:29:58 | Transplantation for Hematologic Disorders Including GVHD | William Hogan, M.B., B.Ch. |
| 0:27:08 | HLH Porphyrias / Acquired Thrombocytopenia (ITP) | Alexandra Wolanskyj-Spinner, M.D. |
| 0:26:46 | Platelet Disorders | Meera Sridharan, M.D., Ph.D. |
| 0:25:18 | Coagulation Factor Disorders: Molecular Basis, Inherited & Acquired Bleeding Disorders | Rajiv Pruthi, M.B.B.S. |
| 0:29:53 | Hemoglobinopathies | Ewa Wysokinska, M.D. |
| 0:26:00 | Nutritional Anemias and Iron Disorders | Ronald Go, M.D. |
| 0:28:54 | Immune Hemolytic Anemia | Surbhi Shah, M.B.B.S. |
| 28:00:23 Content Hours | ||
Official Program Reference
Mayo Clinic’s 2025 online course information. CME and MOC eligibility belongs to the publisher’s separately registered activity and is not included with this store purchase.



